These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17953423)

  • 1. New promises in the adjuvant, and palliative treatment of melanoma.
    Hauschild A; Schadendorf D; Garbe C; Ugurel S; Kähler KC
    Cancer Treat Res; 2007; 135():277-92. PubMed ID: 17953423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug clinics. How I treat cutaneous melanoma].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 1998 Jan; 53(1):4-6. PubMed ID: 9555173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant application of interferons.
    el Kassas H; Kirkwood JM
    Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant interferon in the treatment of melanoma.
    Middleton MR
    Br J Cancer; 1999 Aug; 80(11):1679-80. PubMed ID: 10468281
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant and palliative therapy of melanoma. Current status].
    Tilgen W
    Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re:Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study.
    Lollini PL; Nanni P; de Giovanni C; Nicoletti G; Landuzzi L
    J Natl Cancer Inst; 1996 Jul; 88(13):926-7. PubMed ID: 8656445
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon adjuvant therapy of melanoma.
    Kirkwood JM; Wazer D; Rosenstein M
    Cancer; 1997 May; 79(9):1843-6. PubMed ID: 9129006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of cutaneous melanoma].
    Dummer R; Nestle FO; Hofbauer G; Böni R; Burg G
    Ther Umsch; 1998 Aug; 55(8):509-14. PubMed ID: 9757818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant interferon alfa-2b for high-risk melanoma.
    Retsas S
    J Clin Oncol; 1996 Jun; 14(6):1968-9. PubMed ID: 8656272
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical prognostic factors in adjuvant melanoma trial.
    Nathanson L
    J Clin Oncol; 1996 Jun; 14(6):1967-8. PubMed ID: 8656271
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma--part 2: management.
    Thirlwell C; Nathan P
    BMJ; 2008 Dec; 337():a2488. PubMed ID: 19047194
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systemic treatment of melanoma. Current clinical trials].
    Hauschild A; Rass K; Tilgen W
    Hautarzt; 2008 Jun; 59(6):484-91. PubMed ID: 18478195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant IFN alpha2 therapy of melanoma.
    Kirkwood JM
    Lancet; 1998 Jun; 351(9120):1901-3. PubMed ID: 9654253
    [No Abstract]   [Full Text] [Related]  

  • 15. Finally, a successful adjuvant therapy for high-risk melanoma.
    Balch CM; Buzaid AC
    J Clin Oncol; 1996 Jan; 14(1):1-3. PubMed ID: 8558183
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study.
    Meyskens FL; Kopecky KJ; Taylor CW; Noyes RD; Tuthill RJ; Hersh EM; Feun LG; Doroshow JH; Flaherty LE; Sondak VK
    J Natl Cancer Inst; 1995 Nov; 87(22):1710-3. PubMed ID: 7473820
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
    Johnson DM; Hayat SQ; Burton GV
    J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
    [No Abstract]   [Full Text] [Related]  

  • 18. Meeting report from the Third Global Workshop on Melanoma.
    Agarwala SS; di Pietro A; Flaherty KT; Garbe C; Grob JJ; Kashani-Sabet M; Kirkwood JM; Leachman S; Messina J; O'Day S; Ribas A; Sondak V
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-7. PubMed ID: 20718940
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant therapies for malignant melanoma.
    Olofsson Bagge R; Ny L
    Br J Surg; 2016 Aug; 103(9):1095-6. PubMed ID: 27246114
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon adjuvant therapy of melanoma.
    Nathanson L
    Cancer; 1996 Sep; 78(5):944-7. PubMed ID: 8780530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.